News
BTMDW
1.610
0.00%
0.000
Biote slightly beats Q3 revenue expectations, reaffirms 2025 revenue forecast
Reuters · 11/05 21:38
Biote Corporation Releases Transcript for Second Quarter 2025 Earnings Conference Call
Reuters · 08/08 15:02
BIOTE CORP <BTMD.O>: TRUIST SECURITIES CUTS TARGET PRICE TO $6 FROM $7
Reuters · 08/07 11:13
U.S. RESEARCH ROUNDUP-Applovin, Costco Wholesale, Hubspot
Reuters · 08/07 07:56
Healthcare firm Biote Q2 revenue misses expectations
Reuters · 08/06 21:27
Biote Corp Reports Slight Revenue Dip to $48.9M, Net Income of $3.9M; EPS at $0.10 with Adjusted EBITDA Jumping 19.1%
Reuters · 08/06 20:08
BIOTE NAMES RICH BARRERA TO BOARD OF DIRECTORS
Reuters · 06/09 20:05
Biote Corp reports results for the quarter ended March 31 - Earnings Summary
Reuters · 05/08 00:53
BIOTE CORP - RESTRUCTURING TO REDUCE WORKFORCE BY 16 EMPLOYEES - SEC FILING
Reuters · 05/07 21:10
BRIEF-Biote Q1 Adjusted EBITDA USD 13.8 Million Vs. IBES Estimate USD 13.3 Million
Reuters · 05/07 20:05
BIOTE CORP <BTMD.O>: TRUIST SECURITIES CUTS TARGET PRICE TO $7 FROM $9
Reuters · 03/13 11:35
BRIEF-Biote Q4 Adjusted EBITDA USD 15.1 Million Vs. IBES Estimate USD 16 Million
Reuters · 03/12 20:05
BIOTE CORP - BRET CHRISTENSEN NAMED CEO AND DIRECTOR EFFECTIVE FEBRUARY 1, 2025
Reuters · 01/30 21:10
More
Webull provides a variety of real-time BTMDW stock news. You can receive the latest news about Biote through multiple platforms. This information may help you make smarter investment decisions.
About BTMDW
Biote Corp. operates a practice-building business within the hormone optimization space. The Company provides the necessary components to enable Biote-certified practitioners to establish, build, and implement a program designed to optimize hormone levels. The Company's Biote Method is a comprehensive, end-to-end practice-building platform that provides Biote-certified practitioners with the components specifically developed for practitioners in the hormone optimization space: Biote Method education, training and certification, practice management software, inventory management software, and information regarding available hormone replacement therapy (HRT) products, as well as digital and point-of-care marketing support. It also sells a complementary Biote-branded line of dietary supplements. The Biote Method’s proprietary clinical decision support (CDS) assists physicians in establishing individualized dosing for patients.